Coral Laboratories share news, announcements and annual reports
BSE: 524506Pharmaceuticals & BiotechnologySmall Cap
Coral Laboratories Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1994
Last close ₹484.35down ₹35.65 (6.86%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹520.00.
30 Oct: open ₹540.00, high ₹540.00, low ₹481.50
52-week range of traded prices to 30 Oct 2026
₹360.00Low, 27 Mar 2026₹679.00High, 20 Aug 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹173 Cr2,551st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 9.01
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.83
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.41%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 9.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.02
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,026
Coral Laboratories board meetings
176 filed, newest first. Page 3 of 4.
Sep 2021
20 Sep · Board meeting
Meeting on 27 Sep 2021
Aug 2021
27 Aug · Board meeting
Meeting on 3 Sep 20216 Aug · Board meeting
Meeting on 13 Aug 2021: quarterly results
Jun 2021
22 Jun · Board meeting
Meeting on 28 Jun 2021: audited results
May 2021
20 May · Board meeting
Meeting on 27 May 2021
Feb 2021
3 Feb · Board meeting
Meeting on 11 Feb 2021: quarterly results
Nov 2020
4 Nov · Board meeting
Meeting on 12 Nov 2020: quarterly results
Sep 2020
4 Sep · Board meeting
Aug 2020
31 Aug · Board meeting
Meeting on 4 Sep 2020: quarterly results
Jul 2020
23 Jul · Board meeting
17 Jul · Board meeting
Meeting on 23 Jul 2020
Jun 2020
15 Jun · Board meeting
Meeting on 19 Jun 2020
May 2020
15 May · Board meeting
Meeting on 20 May 2020: audited results
Feb 2020
3 Feb · Board meeting
Meeting on 12 Feb 2020: quarterly results
Nov 2019
4 Nov · Board meeting
Meeting on 12 Nov 2019: quarterly results
Aug 2019
5 Aug · Board meeting
Meeting on 12 Aug 2019: annual general meeting and quarterly results
May 2019
20 May · Board meeting
Meeting on 28 May 2019: audited results and dividend
Feb 2019
Jan 2019
24 Jan · Board meeting
Meeting on 5 Feb 2019: quarterly results
Oct 2018